What is ICLR stock price today?

ICLR (Icon Plc) stock is trading at $113.06 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ICLR stock going up or down today?

ICLR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ICLR stock now?

The decision to buy ICLR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ICLR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ICLR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ICLR stock overvalued or undervalued?

ICLR currently trades at a P/E ratio of 14.87, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if ICLR is fairly priced.

What is ICLR's P/E ratio?

ICLR has a price-to-earnings (P/E) ratio of 14.87, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ICLR's market cap?

ICLR (Icon Plc) has a market capitalization of $8.58 billion, making it a small-cap stock.

What is ICLR's price to book ratio?

ICLR trades at a price-to-book (P/B) ratio of 0.87, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does ICLR pay dividends?

ICLR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ICLR's dividend yield?

ICLR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ICLR stock a good long-term investment?

ICLR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ICLR's revenue growth rate?

ICLR has shown revenue growth of 0.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, ICLR is profitable with a profit margin of 0.1%. This indicates the company generates 0.1 cents of profit for every dollar of revenue.

What are the risks of investing in ICLR?

Key risks for ICLR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ICLR compare to its competitors?

Compare ICLR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ICLR's performance and positioning.

What is ICLR's stock price target for 2026?

Our AI model provides price targets for ICLR based on fundamental analysis: Bull case $146.98 (+30%), Base case $130.02 (+15%), Bear case $101.75 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ICLR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ICLR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ICLR's next earnings report?

ICLR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ICLR - Icon Plc

NYSE * Health Care * Life Sciences Tools & Services

$113.06

+$2.69 (+2.44%)

About Icon Plc

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.

ICLR Key Statistics

Market Cap

$8.58B

P/E Ratio

14.87

P/B Ratio

0.87

EPS

$7.42

Revenue Growth

+0.0%

Profit Margin

0.1%

Employees

39,800

How ICLR Compares to Peers

ICLR has the lowest P/E ratio in Life Sciences Tools & Services, suggesting it may be the most undervalued

ICLR is the smallest among peers, which may offer higher growth potential

P/E Rank

of 2

Margin Rank

of 2

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
ICLR(This stock)	$8.58B	14.9	0%	0.1%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Icon Plc Company Information

Headquarters: Ireland
Website: www.iconplc.com
Sector: Health Care
Industry: Life Sciences Tools & Services

About Icon Plc

ICLR Key Statistics

How ICLR Compares to Peers

Icon Plc Company Information

Upcoming Events for ICLR